Barclays’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.6M | Buy |
138,415
+60,086
| +77% | +$5.03M | ﹤0.01% | 1076 |
|
|
2025
Q1 | $5.6M | Sell |
78,329
-48,346
| -38% | -$3.45M | ﹤0.01% | 1349 |
|
|
2024
Q4 | $5.69M | Buy |
126,675
+74,130
| +141% | +$3.33M | ﹤0.01% | 1486 |
|
|
2024
Q3 | $2.65M | Buy |
52,545
+31,467
| +149% | +$1.59M | ﹤0.01% | 1973 |
|
|
2024
Q2 | $861K | Buy |
21,078
+459
| +2% | +$18.7K | ﹤0.01% | 2199 |
|
|
2024
Q1 | $882K | Sell |
20,619
-686
| -3% | -$29.3K | ﹤0.01% | 2496 |
|
|
2023
Q4 | $858K | Buy |
+21,305
| New | +$858K | ﹤0.01% | 2708 |
|
|
2021
Q4 | – | Sell |
-455
| Closed | -$6K | – | 3766 |
|
|
2021
Q3 | $6K | Buy |
455
+16
| +4% | +$211 | ﹤0.01% | 3815 |
|
|
2021
Q2 | $8K | Sell |
439
-2,881
| -87% | -$52.5K | ﹤0.01% | 3916 |
|
|
2021
Q1 | $63K | Buy |
3,320
+2,038
| +159% | +$38.7K | ﹤0.01% | 3489 |
|
|
2020
Q4 | $37K | Sell |
1,282
-527
| -29% | -$15.2K | ﹤0.01% | 3275 |
|
|
2020
Q3 | $68K | Buy |
1,809
+590
| +48% | +$22.2K | ﹤0.01% | 3167 |
|
|
2020
Q2 | $40K | Buy |
+1,219
| New | +$40K | ﹤0.01% | 3456 |
|